MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
January 05 2017 - 9:00AM
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD), focused on the
discovery and development of therapeutic products for diabetes,
will present today at the 35th Annual J.P. Morgan Healthcare
Conference at 10:00 AM (PST) at the Westin St. Francis Hotel in San
Francisco, California.
Presenting from the Company will be its Chief
Executive Officer, Matthew J. Pfeffer.
Interested parties can access a link to the live
webcast of the presentations from the News & Events section of
the Company's website at http://www.mannkindcorp.com.
About MannKind CorporationMannKind
Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the discovery
and development of therapeutic products for patients with diseases
such as diabetes. MannKind maintains a website at
http://www.mannkindcorp.com to which MannKind regularly posts
copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind
website to e-mail alerts that are sent automatically when MannKind
issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the
website.
Company Contact:
Rose Alinaya
SVP Finance
661-775-5300
ralinaya@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jun 2024 to Jul 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jul 2023 to Jul 2024